Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: The present disclosure relates to a light guide plate and its manufacturing method, and a backlight module. The light guide plate includes two opposite main surfaces and a side surface located between the two main surfaces. The method comprises: forming a plurality of grooves on at least one main surface of the light guide plate.

Abstract: A packaging structure and a packing method for a display panel are provided, the display panel includes a display panel body (201) and a circuit board (202), and the packaging structure of the display panel includes: a box body (301) including an inner chamber and an opening at an upper surface of the box body (301); and at least one support division plate (302) provided in the inner chamber of the box body. The support division plate (302) is configured to be perpendicular to the upper surface of the box body (301) and to divide the inner chamber of the box body (301) into a plurality of vertical placement spaces, so that each of the placement spaces is configured for the display panel (20) to be vertically placed therein with a display surface of the display panel body (201) placed in the placement space being perpendicular to the upper surface (w) of the box body.

Abstract: Embodiments of the present disclosure provide a pixel circuit, a driving method thereof and a display device comprising the pixel circuit. The pixel circuit comprises a display unit and a first precharge unit; the first precharge unit is connected to the display unit, a (N?1)th scan line and a control line, and is configured to convert light energy into electric energy and to precharge the display unit with the converted electric energy under the control of the control line and the (N?1)th scan line; the display unit is further connected to the Nth scan line and a data line and is configured to charge the display unit through the data line under the control of the Nth scan line; wherein N?2.

Abstract: The present invention provides a touch system and a display device, belongs to the technical field of display, and can solve the problem that misoperation is caused as an existing touch screen has a narrow frame and the edge area of the screen is easy to touch mistakenly. The touch system comprises a touch screen, a touch position analysis unit and a switch unit, wherein the touch screen comprises a center touch area and an edge touch area, and the touch position analysis unit is used for analyzing a position of a touch on the touch screen; and the switch unit is used for controlling whether a touch on the edge touch area is effective.

Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.

Abstract: The embodiments of the present disclosure provide an optical assembly and a liquid crystal display device using the optical assembly. The optical assembly has a simple structure and low cost, and can realize a high color gamut display. The optical assembly comprises a first substrate layer, a second substrate layer, and an optical fiber layer arranged between the first substrate layer and the second substrate layer. The optical fiber layer is composed of a plurality of optical fibers arranged closely in a single layer. A plurality of adhesive blocks in contact with the plurality of optical fibers are arranged on a surface of at least one of the first substrate layer and the second substrate layer. At the contact regions between the adhesive blocks and the plurality of optical fibers, total internal reflection in the optical fibers is inhibited by the adhesive blocks.

Abstract: A prism sheet, a curved backlight source and a display device are disclosed. The prism sheet includes a substrate and a plurality of prism units arranged on the substrate in an array. Each of the prism units has a triangular cross-section which has a first base angle and a second base angle, and both the first base angle and the second base angle are at a side of the cross-section close to the substrate. The degrees of the first and second base angles of the triangular cross-section of at least one of the plurality of prism units are different from each other. By means of the prism sheet, the backlight source and the display device according to the embodiments of the present invention, the uniformity of brightness of the emitted light may be improved, the visual angle may be increased, and as a result, the visual effect may be improved.

Abstract: The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquin oline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

Abstract: The present invention provides a backlight and a display device. The backlight includes a frame and an optical film set including a plurality of optical films that are successively stacked. Each optical film in the optical film set includes a film body and an ear part. In any two adjacent optical films, the boundary of at least one side of the ear part of the lower optical film extends beyond the boundary of the same side of the ear part of the upper optical film. A fixing member covers the ear parts of the plurality of optical films, such that the optical film set is fixed on the frame, and the fixing member can fix the relative positions among the plurality of optical films in the optical film set. In the backlight, the optical film set is reliably fixed without affecting the normal display on the display device.

Abstract: The present invention relates to aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, and the use of such aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives for therapeutic purposes. The aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to aminotetraline and aminoindane derivatives of the formula (I) or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such aminotetraline and aminoindane derivatives, and the use of such aminotetraline and aminoindane derivatives for therapeutic purposes. The aminotetraline and aminoindane derivatives are GlyT1 inhibitors.

Abstract: The present invention relates to 4,5-dihydropyrazole derivatives of the formula (I) and physiologically tolerated salts thereof which are GlyT1 inhibitors. The invention further relates to pharmaceutical compositions comprising such 4,5-dihydropyrazole derivatives, and the use of such 4,5-dihydropyrazole derivatives for therapeutic purposes.

Abstract: The present disclosure discloses a method, a device, and a system for displaying media data, which belong to the field of information processing technologies. The method includes: determining at least one piece of media data corresponding to a data display position; acquiring predicted click information and predicted display information corresponding to each piece of media data; and selecting one piece of media data from all the media data according to the predicted click information and the predicted display information corresponding to each piece of media data and displaying the selected media data on the data display position.

Abstract: A method for allocating an information display amount includes: determining an estimated display amount of unallocated information according to a total original display amount of all information display units and a displayed amount of allocated information; acquiring a predetermined display amount of the unallocated information according to the estimated display amount of the unallocated information; and allocating information displayed by each information display unit and a display amount according to the predetermined display amount of the unallocated information and a remaining display amount of the allocated information.

Abstract: A method and a system for processing network media information are provided. The method includes: collecting historical distribution effect data of network media information; performing attribute improvement processing on the historical distribution effect data by using population attribute data and network media information management data to obtain characteristic attribute data; constructing an effect parameter estimation model corresponding to each attribute of the characteristic attribute data, and training the effect parameter estimation model; estimating an effect parameter value of each audience for target network media information according to the effect parameter estimation model; and selecting an audience whose estimated effect parameter value is greater than or equal to a specified threshold value to form an audience population package to be extracted.

Abstract: A detecting device for light-emitting property of a light source is provided and the detecting device for light-emitting property of a light source includes: a positioning device configured for fixing the light source; and a detection apparatus configured for acquiring a parameter of an emergent light from the light source. The detecting device for light-emitting property of a light source can detect the light-emitting property of the light source, thus help to select the chrominance and brightness degree, of a light source, required by a display module, and shorten the researching and manufacturing period for a liquid crystal display.

Abstract: A packaging structure and a packing method for a display panel are provided, the display panel includes a display panel body (201) and a circuit board (202), and the packaging structure of the display panel includes: a box body (301) including an inner chamber and an opening at an upper surface of the box body (301); and at least one support division plate (302) provided in the inner chamber of the box body. The support division plate (302) is configured to be perpendicular to the upper surface of the box body (301) and to divide the inner chamber of the box body (301) into a plurality of vertical placement spaces, so that each of the placement spaces is configured for the display panel (20) to be vertically placed therein with a display surface of the display panel body (201) placed in the placement space being perpendicular to the upper surface (w) of the box body.

Abstract: The present application relates to aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives of formula (I) wherein R1, R2, R3, R4, R5, A, Y1, Y2, and Y3 are as defined in the specification. The present application also relates to compositions comprising such compounds, processes for making such compounds, and methods of treating disease conditions using such compounds and compositions, and methods for identifying such compounds.